152 related articles for article (PubMed ID: 3877562)
21. Circulating immune complexes in patients with malignant lymphomas and solid tumors.
Heier HE; Carpentier N; Lange G; Lambert PH; Godal T
Int J Cancer; 1977 Dec; 20(6):887-94. PubMed ID: 338514
[TBL] [Abstract][Full Text] [Related]
22. Serial measurement of circulating immune complexes in healthy subjects.
Puskás E; Füst G; Angyal I; Nguyen-Chi-Phi ; Gergely J
Immunol Lett; 1982 Apr; 4(4):223-7. PubMed ID: 6807843
[TBL] [Abstract][Full Text] [Related]
23. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
24. Circulating antigen-antibody complexes in onchocerciasis.
Steward MW; Sisley B; Mackenzie CD; El Sheikh H
Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
Larson RA; Lukin CL; Daly KM; Mick R; Gore S; Le Beau MM
Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
[TBL] [Abstract][Full Text] [Related]
26. Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC).
Migliorini P; Aiuti F; Balestrieri G; Bombardieri S; Cantarella S; Carbonara A; Clerici E; Coppo R; Cordiali Fei P; D'Amelio R
Clin Immunol Immunopathol; 1984 Sep; 32(3):298-315. PubMed ID: 6235997
[TBL] [Abstract][Full Text] [Related]
27. Changes in circulating immune complexes in tumour patient serum after in vitro or ex vivo affinity chromatography of blood plasma or whole blood over immunoglobulin-binding staphylococcal protein A-Sepharose.
Håkansson L; Hed J; Baldetorp L; Eneström S; Jonsson S; Liedén G
Int J Artif Organs; 1984 Jan; 7(1):23-6. PubMed ID: 6365797
[TBL] [Abstract][Full Text] [Related]
28. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
31. Serial measurement of circulating immune complexes in the sera of patients with leukaemia.
Mód A; Carpentier N; Füst G; Lambert PH; Miescher P; Hollán SR
J Clin Lab Immunol; 1980 Jul; 4(1):15-20. PubMed ID: 7007648
[TBL] [Abstract][Full Text] [Related]
32. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis.
Sisley BM; Mackenzie CD; Steward MW; Williams JF; O'Day J; Luty AJ; Braga M; el Sheikh H
Parasite Immunol; 1987 Jul; 9(4):447-63. PubMed ID: 3498141
[TBL] [Abstract][Full Text] [Related]
33. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
34. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
Heier HE; Landaas TO; Marton PF
Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
[TBL] [Abstract][Full Text] [Related]
35. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
Lin RY; Racis SP
Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
[TBL] [Abstract][Full Text] [Related]
36. Reactivity of low molecular weight material in cellular immune complex assays.
Cooper KM; Moore M
Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
[TBL] [Abstract][Full Text] [Related]
37. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
38. Circulating immune complexes in regularly dialyzed patients with chronic renal failure.
Perez GO; Glasson P; Favre H; Wauters JP; Benzonana G; Jeannet M; Lambert PH
Am J Nephrol; 1984; 4(4):215-21. PubMed ID: 6236693
[TBL] [Abstract][Full Text] [Related]
39. Circulating immune complexes in cervical cancer patients as detected by C1q binding.
Chao KC; Liu CC; Ng HT; Hu CP; Chang CM
Proc Natl Sci Counc Repub China B; 1984 Jan; 8(1):50-3. PubMed ID: 6335756
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
